Source: American heart journal. Unidade: FM
Subjects: CORAÇÃO, FÁRMACOS, MIOCARDIOPATIAS
ABNT
COSTA, Isabela Bispo Santos da Silva et al. Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: design and rationale of the CARDIOTOX trial. American heart journal, v. 285, p. 1-11, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84783. Acesso em: 03 nov. 2025.APA
Costa, I. B. S. da S., Furtado, R. H. M., Drager, L. F., Silva, P. G. M., Melo, M. D. T. de, Araruna, P., et al. (2025). Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: design and rationale of the CARDIOTOX trial. American heart journal, 285, 1-11. doi:10.1016/j.ahj.2025.02.014NLM
Costa IBS da S, Furtado RHM, Drager LF, Silva PGM, Melo MDT de, Araruna P, Bacchiega BC, Cauduro S, Hajjar LA, Kalil Filho R. Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: design and rationale of the CARDIOTOX trial [Internet]. American heart journal. 2025 ; 285 1-11.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84783Vancouver
Costa IBS da S, Furtado RHM, Drager LF, Silva PGM, Melo MDT de, Araruna P, Bacchiega BC, Cauduro S, Hajjar LA, Kalil Filho R. Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: design and rationale of the CARDIOTOX trial [Internet]. American heart journal. 2025 ; 285 1-11.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84783

